BELLEVUE, WA, Dec. 11 /PRNewswire-FirstCall/ -- Oncothyreon Inc. (NASDAQ: ONTY) (TSX:ONY) today announced that its common stock will begin trading on the Nasdaq Global Market under the symbol...
EDMONTON, Dec. 5 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) ("Biomira", the "Company") announced that the Alberta Court of Queen's Bench today issued a Final Order approving...
EDMONTON, Dec. 4 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) ("Biomira", the "Company") today announced that the Company's shareholders have approved a plan of arrangement...
EDMONTON, Nov. 5 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) (the "Company") today announced that on November 2, 2007, it received a letter from The Nasdaq Stock Market, Inc...
EDMONTON, and BELLEVUE, WA, Nov. 1 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) (the "Company") today announced that it will hold a special meeting of shareholders at 9:00...
EDMONTON, Nov. 1 /PRNewswire-FirstCall/ -- Biomira Inc. ("Biomira" or the "Company") (NASDAQ:BIOM) (TSX:BRA) today reported a consolidated net loss of $6.8 million or $0.06 per basic and diluted...
EDMONTON, Oct. 30 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) today announced that Robert Kirkman, M.D., President and Chief Executive Officer, is scheduled to present at the...
EDMONTON, Oct. 24 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) announced today that preclinical data for its targeted anti-cancer drug candidates PX-478 and PX-866 were...
EDMONTON, Oct. 3 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) today announced that Robert Kirkman, M.D., President and Chief Executive Officer, is scheduled to present at the...
EDMONTON, Sept. 27 /PRNewswire-FirstCall/ -- Biomira Inc. (NASDAQ:BIOM) (TSX: BRA) (the "Company") today announced that, as part of the Company's previously announced plan to reincorporate in...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관